Journals / Türkiye Acil Tıp Dergisi / 2007 / Cilt: 7 - Sayı: 2

Tricyclic antidepressant poisoning on emergency department: critical patients

Acil serviste trisiklik antidepresan zehirlenmeleri: Kritik hastalar

Pages
86–95
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Administration of hypertonic saline, glucagone, adenosine antagonists and TCA-antibodies has also been of benefit in this patient's treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tricydic antidepressant's (TCA) are used primarily for the treatment of major depression.
📊
Key Findings & Data:Indications for sodi¬um bicarbonate therapy include QRS complex widening greater than WO ms, hypotension refractory to fluid hydration, terminal right axis deviation aVr of greater than 3 mm, ventricular dysrhythmias, cardiac arrest, aci-dosis and seizure.
💡
Conclusion & Impact:Administration of hypertonic saline, glucagone, adenosine antagonists and TCA-antibodies has also been of benefit in this patient's treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tricydic antidepressant's (TCA) are used primarily for the treatment of major depression. TCA overdose is a life threatening situation which is commonly seen in the emergency department. The clinical presentation of TCA toxicity varies tremendously from mild antimuscarinic symptoms to severe cardiotoxicity. The most common tox¬icity occurs in cardiovascular, the peripheral nervous system and the central nervous system. Indications for sodi¬um bicarbonate therapy include QRS complex widening greater than WO ms, hypotension refractory to fluid hydration, terminal right axis deviation aVr of greater than 3 mm, ventricular dysrhythmias, cardiac arrest, aci-dosis and seizure. Administration of hypertonic saline, glucagone, adenosine antagonists and TCA-antibodies has also been of benefit in this patient's treatment.

Özet

Trisiklik antidepresan (TSA) ilaçlar esas olarak majör depresyon tedavisinde kullanılırlar. Acil servislerde TSA zehir¬lenmeleri sık görülen ve yaşamı tehdit eden zehirlenmelerdir. TSA toksisitesinin kliniği hafif antimuskarinik bulgu¬lardan ağır kardiyotoksisiteye kadar değişebilir. En ağır toksisite kardiyovasküler, periferik sinir sistemi ve santral sinir sistemi üzerinedir. TSA zehirlenmesinde sodyum bikarbonat tedavi endikasyonları, 100 ms'den uzun QRS sü¬resi, sıvı tedavisine dirençli hipotansiyon, aVr'de 3 mm'den daha fazla terminal sağ aks sapması, ventriküler arit¬miler, kardiyak arrest, asidoz ve nöbettir. Bu hastaların tedavisinde hipertonik şalin, glukagon, adenozin antago-nistleri ve TSA antikorlarının kullanılması da yararlıdır.

🔖

Cite This Article

ÜNVERİR, P. (2022). Tricyclic antidepressant poisoning on emergency department: critical patients. Türkiye Acil Tıp Dergisi, Cilt: 7 - Sayı: 2, 86–95. https://ajindex.com/articles/626157

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Potter WZ, Hollister LE. Antidepressant agents. In: Katzung BG, editor. Basic and clinical pharmacology. A LANGE medical book. McGraw-Hill; 2004. p. 482-96. 2.Mills KC. Tricyclic antidepressants. In: Tintinalli JE, Kelen GD, Stapczynski JS, editors. Emergency medicine a comprehensive study guide. 6th ed. New York: McGraw-Hill; 2004. p. 1025-33. 3.Liebelt EL, Francis PD. Cyclic antidepressants. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, editors. Goldfrank's toxicologic emergencies. 7th ed. New York: McGraw-Hill; 2002. p. 847-64. 4.Bosch TM, van der Werf TS, Uges DR, Ligtenberg JJ, Fijen JW, Tulleken JE, et al.Antidepressants self-poisoning and ICU admissions in a university hospital in The Netherlands. Pharm World Sci 2000;22:92-5. 5.Phillips S, Brent J, Kulig K, Heiligenstein J, Birkett M. Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses.The Antidepressant Study Group. J Emerg Med 1997;15:439-45. 6.Graudins A, Dowsett RP, Liddle C. The toxicity of antidepressant poisoning: is it changing? A comparative study of cyclic and newer serotonin-specific antidepressants. Emerg Med (Fremantle) 2002; 14:440-6. 7.Ramchandani P, Murray B, Hawton K, House A. Deliberate self poisoning with antidepressant drugs: a comparison of the relative hospital costs of cases of overdose of tricyclics with those of selective-serotonin re-uptake inhibitors. / Affect Z)wo7-d2000;60:97-100. 8.Arranto CA, Mueller C, Hunziker PR, Marsch SC, Eriksson U. Adverse cardiac events in ICU patients with presumptive antidepressant overdose. Swiss Med Wkly 2003; 133:479-83. 9.Bateman DN, Chick J, Goo.d AM, Kelly CA, Masterton G. Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose? Eur J Clin Pharmacol 2004;60:221-4. 10.Legome E. Toxicity antidepressant. Emergency medicine online textbook. Available at: http:// www.emedicine.com. Accessed: Jan 5, 2006. 11.Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J, et al.2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005;23:589-666. 12.Bigwood B, Galler D, Amir N, Smith W. Brugada syndrome following tricyclic antidepressant overdose. Anaesth Intensive Care 2005;33:266-70. 13.Benowitz NL. Tricyclic antidepressants. In: Olson KR, editor. Poisoning and drug overdose. USA: Appleton and Lange; 1999. p. 310-12. 14.